Georgia’s food-supplement rules are, on paper, closely modelled on the European framework. The gap the Public Health Institute of Georgia (PHIG) documents in its ongoing market reviews is not legislative — it is the distance between what the law requires and what products on shelves can actually demonstrate.
- What the law requires
- What compliance reviews find
- Why enforcement is limited
- What consumers can do now
- The approximation timeline: why EU rules govern a non-EU market
- Anatomy of a compliant label: the checklist
- How a market review is actually conducted
- What good enforcement looks like: models worth importing
- The clinical bottom line
- Primary sources
What the law requires
The EU’s Directive 2002/46/EC — the reference framework for Georgian approximation under the Association Agreement — defines supplements as concentrated nutrient sources in dose form, restricts vitamins and minerals to positive-listed substances (Annexes I–II), and mandates labelling that includes recommended daily dose, a warning not to exceed it, a statement that supplements do not replace a varied diet, and a keep-away-from-children notice. Georgian food legislation adds the national layer: business-operator registration with the National Food Agency, product notification before marketing, Georgian-language labelling, and traceability sufficient for recall. Together this creates a three-part legal minimum: legal ingredients, compliant label, registered and traceable operator.
What compliance reviews find
PHIG’s investigative documentation of products sold in Georgia — pharmacy chains, retail, and online/imported channels — repeatedly surfaces the same failure categories. No certificate of analysis: distributors unable to produce any batch-level CoA, meaning identity and potency of the actual lot are undemonstrated. No heavy-metal or contaminant testing: no lead/arsenic/cadmium/mercury data for products whose ingredient classes (botanical extracts, marine oils, clays) are precisely the higher-risk categories. Labelling failures: missing Georgian-language labels on imports, absent mandatory warnings, undeclared dosage-exceedance cautions, and claims language crossing into prohibited disease-treatment territory. Registration gaps: parcel-import and social-media sales operating entirely outside NFA notification — beyond the recall system’s reach. Individual product cases from these reviews are handled through formal regulatory correspondence rather than publication; the categories above are the market-level pattern.
Why enforcement is limited
Three structural reasons. Supplement oversight competes for the same inspection capacity as core food safety; post-market laboratory surveillance (buying and testing shelf products) is resource-intensive and therefore rare; and cross-border e-commerce places a growing share of the market outside territorial jurisdiction altogether. None of this is unique to Georgia — but a smaller market feels each constraint more sharply.
What consumers can do now
Until enforcement catches up with the framework, verification burden sits with the buyer, and three questions do most of the work: Is the product NFA-notified (a registered importer will say so)? Can the seller produce a batch-specific CoA from an accredited laboratory, including heavy metals? Does the label carry the mandatory statements in Georgian? A “no” to any of these is a stronger signal than any marketing claim.
The approximation timeline: why EU rules govern a non-EU market
Georgia’s supplement framework is not voluntarily EU-flavoured — it is treaty-bound. The 2014 EU–Georgia Association Agreement, with its Deep and Comprehensive Free Trade Area, obliges Georgia to approximate defined chapters of the EU food-safety acquis on a scheduled basis, Directive 2002/46/EC among the reference acts, with the National Food Agency as the competent authority whose functions mirror member-state models. The strategic logic is export access: Georgian food products reach EU markets only through demonstrable regulatory equivalence. For consumers the practical consequence is convenient — the compliance questions to ask in Tbilisi are the same ones asked in Vilnius or Lisbon, and the EU’s public documents (positive lists, labelling rules, RASFF alerts) function as a free reference library for the Georgian market.
Anatomy of a compliant label: the checklist
A supplement label meeting the 2002/46/EC-derived requirements carries, at minimum: the sales name including the word designating it a food supplement; the nutrient/substance categories characterising it; the recommended daily portion with a warning not to exceed it; nutrient amounts declared per that daily portion, with vitamins and minerals also as % NRV; the statement that supplements are not a substitute for a varied diet; the keep-out-of-reach-of-children notice; and — the national layer — all of it in Georgian, with a named responsible operator reachable at a Georgian address. Each element is checkable in thirty seconds at a shelf, which is exactly what makes labelling audits the highest-yield, lowest-cost compliance instrument a reviewer has.
How a market review is actually conducted
PHIG’s methodology follows standard market-surveillance practice, kept at pattern level here by design. Sampling frame: products drawn across the three retail channels — pharmacy chains, physical retail, and online/social-media import sellers — because compliance stratifies sharply by channel. Document request: each seller/distributor asked for the two artefacts the law presumes to exist: proof of NFA notification, and a batch-specific certificate of analysis including identity, potency and heavy metals. Label audit: the checklist above, item by item. Classification: findings recorded as failure categories rather than brand verdicts, with individual cases routed into formal regulatory correspondence — the channel where naming names belongs, with due process attached. The published output is therefore a market diagnosis, not a blacklist: deliberately.
What good enforcement looks like: models worth importing
The gap being administrative capacity rather than legal text, the fixes are known machinery. Risk-based post-market testing — concentrating laboratory budgets on the categories where alerts cluster (botanical slimming and enhancement products, imported protein powders). Alert-network integration — full exploitation of RASFF and WHO INFOSAN feeds so that a batch flagged in Warsaw is checked in Tbilisi within days. Channel enforcement — treating social-media sellers as food business operators with registration duties, as EU market-surveillance practice increasingly does. And publication of surveillance results in aggregate, which disciplines the market without litigating individual reputations. Each of these is incremental, budgetable, and proven elsewhere — the encouraging part of an otherwise sobering audit.
The clinical bottom line
Georgia’s supplement law is EU-shaped; the documented market is not yet. The recurring failures are demonstrability failures — no CoA, no contaminant data, no compliant label — which is exactly why independent batch testing and transparent registration are the trust signals worth demanding.
Primary sources
- Directive 2002/46/EC on food supplements (consolidated)
- National Food Agency of Georgia — registration and control functions
- WHO: food-safety surveillance and INFOSAN framework
- PHIG market-review documentation, 2025–2026 (institutional file; regulatory correspondence basis)
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
